Performance analysis of automated evaluation of antinuclear antibody indirect immunofluorescent tests in a routine setting

Mahler M, Meroni PL, Bossuyt X, Fritzler MJ (2014) Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. J Immunol Res 2014:315179–315195

Chan EK, Damoiseaux J, Carballo OG, Conrad K, de Melo Cruvinel W, Francescantonio PL, Fritzler MJ, Garcia-De La Torre I, Herold M, Mimori T, Satoh M, von Muhlen CA, Andrade LE (2015) Report of the first international consensus on standardized nomenclature of antinuclear antibody hep-2 cell patterns 2014–2015. Front Immunol 6:412

Agmon-Levin N, Damoiseaux J, Kallenberg C, Sack U, Witte T, Herold M, Bossuyt X, Musset L, Cervera R, Plaza-Lopez A, Dias C, Sousa MJ, Radice A, Eriksson C, Hultgren O, Viander M, Khamashta M, Regenass S, Andrade LE, Wiik A, Tincani A, Ronnelid J, Bloch DB, Fritzler MJ, Chan EK, Garcia-De La Torre I, Konstantinov KN, Lahita R, Wilson M, Vainio O, Fabien N, Sinico RA, Meroni P, Shoenfeld Y (2014) International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis 73:17–23

Chan EK, Damoiseaux J, de Melo Cruvinel W, Carballo OG, Conrad K, Francescantonio PL, Fritzler MJ, Garcia-De La Torre I, Herold M, Mimori T, Satoh M, von Muhlen CA, Andrade LE (2016) Report on the second international consensus on ana pattern (icap) workshop in dresden 2015. Lupus 25:797–804

Mariz HA, Sato EI, Barbosa SH, Rodrigues SH, Dellavance A, Andrade LE (2011) Pattern on the antinuclear antibody-hep-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases. Arthritis Rheum 63:191–200

Damoiseaux J, von Muhlen CA, Garcia-De La Torre I, Carballo OG, de Melo Cruvinel W, Francescantonio PL, Fritzler MJ, Herold M, Mimori T, Satoh M, Andrade LE, Chan EK, Conrad K (2016) International consensus on ana patterns (icap): the bumpy road towards a consensus on reporting ana results. Auto Immun Highlights 7:1

Bossuyt X, Hendrickx A, Frans J (2005) Antinuclear antibody titer and antibodies to extractable nuclear antigens. Arthritis Rheum 53:987–988

Meroni PL, Bizzaro N, Cavazzana I, Borghi MO, Tincani A (2014) Automated tests of ana immunofluorescence as throughput autoantibody detection technology: strengths and limitations. BMC Med 12:38

Bizzaro N, Antico A, Platzgummer S, Tonutti E, Bassetti D, Pesente F, Tozzoli R, Tampoia M, Villalta D, Study Group on Autoimmune Diseases of the Italian Society of Laboratory Medicine I (2014) Automated antinuclear immunofluorescence antibody screening: A comparative study of six computer-aided diagnostic systems. Autoimmun Rev 13:292–298

Van den Bremt S, Schouwers S, Van Blerk M, Van Hoovels L (2017) Ana IIf automation: moving towards harmonization? Results of a multicenter study. J Immunol Res 2017:6038137

Voigt J, Krause C, Rohwader E, Saschenbrecker S, Hahn M, Danckwardt M, Feirer C, Ens K, Fechner K, Barth E, Martinetz T, Stocker W (2012) Automated indirect immunofluorescence evaluation of antinuclear autoantibodies on hep-2 cells. Clin Dev Immunol 2012:651058

Gerlach S, Affeldt K, Pototzki L, Krause C, Voigt J, Fraune J, Fechner K (2015) Automated evaluation of crithidia luciliae based indirect immunofluorescence tests: a novel application of the europattern-suite technology. J Immunol Res 2015:742402

Krause C, Ens K, Fechner K, Voigt J, Fraune J, Rohwader E, Hahn M, Danckwardt M, Feirer C, Barth E, Martinetz T, Stocker W (2015) Europattern suite technology for computer-aided immunofluorescence microscopy in autoantibody diagnostics. Lupus 24:516–529

Fraune J, Gerlach S, Rentzsch K, Teegen B, Lederer S, Affeldt K, Fechner K, Danckwardt M, Voigt J, Probst C, Komorowski L, Stocker W (2016) Multiparametric serological testing in autoimmune encephalitis using computer-aided immunofluorescence microscopy (caifm). Autoimmun Rev 15:937–942

Hormann W, Hahn M, Gerlach S, Hochstrate N, Affeldt K, Giesen J, Fechner K, Damoiseaux J (2017) Performance analysis of automated evaluation of crithidia luciliae-based indirect immunofluorescence tests in a routine setting—strengths and weaknesses. Clin Chem Lab Med 56:86–93

Cohen J (1968) Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 70:213–220

Landis JR, Koch GG (1977) An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 33:363–374

Sack U, Knoechner S, Warschkau H, Pigla U, Emmrich F, Kamprad M (2003) Computer-assisted classification of hep-2 immunofluorescence patterns in autoimmune diagnostics. Autoimmun Rev 2:298–304

Hu Y, Murphy RF (2004) Automated interpretation of subcellular patterns from immunofluorescence microscopy. J Immunol Methods 290:93–105

Hiemann R, Hilger N, Sack U, Weigert M (2006) Objective quality evaluation of fluorescence images to optimize automatic image acquisition. Cytometry A 69:182–184

Glory E, Murphy RF (2007) Automated subcellular location determination and high-throughput microscopy. Dev Cell 12:7–16

Rigon A, Soda P, Zennaro D, Iannello G, Afeltra A (2007) Indirect immunofluorescence in autoimmune diseases: assessment of digital images for diagnostic purpose. Cytometry B Clin Cytom 72:472–477

Tozzoli R, Bonaguri C, Melegari A, Antico A, Bassetti D, Bizzaro N (2013) Current state of diagnostic technologies in the autoimmunology laboratory. Clin Chem Lab Med 51:129–138

Damoiseaux JG, Tervaert JW (2006) From ana to ena: how to proceed? Autoimmun Rev 5:10–17

Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, Gordon T, Hardin JA, Kalden JR, Lahita RG, Maini RN, McDougal JS, Rothfield NF, Smeenk RJ, Takasaki Y, Wiik A, Wilson MR, Koziol JA (1997) Range of antinuclear antibodies in “healthy” individuals. Arthritis Rheum 40:1601–1611

Op De Beeck K, Vermeersch P, Verschueren P, Westhovens R, Marien G, Blockmans D, Bossuyt X (2011) Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay. Autoimmun Rev 10:801–808

Avery TY, van de Cruys M, Austen J, Stals F, Damoiseaux JG (2014) Anti-nuclear antibodies in daily clinical practice: prevalence in primary, secondary, and tertiary care. J Immunol Res 2014:401739

Fritzler MJ (2016) Choosing wisely: review and commentary on anti-nuclear antibody (ana) testing. Autoimmun Rev 15:272–280

Alsuwaidi M, Dollinger M, Fleck M, Ehrenstein B (2016) The reliability of a novel automated system for ana immunofluorescence analysis in daily clinical practice. Int J Rheumatol 2016:6019268

Loock CD, Egerer K, Feist E, Burmester GR (2017) Automated evaluation of ana under real-life conditions. RMD Open 3:e000409

Zheng B, Li E, Zhu H, Lu J, Shi X, Zhang J, Li M (2017) Automated antinuclear immunofluorescence antibody analysis is a reliable approach in routine clinical laboratories. Clin Chem Lab Med 55:1922–1930

Shovman O, Agmon-Levin N, Gilburd B, Martins T, Petzold A, Matthias T, Shoenfeld Y (2015) A fully automated IIf system for the detection of antinuclear antibodies and antineutrophil cytoplasmic antibodies. Immunol Res 61:135–140

Melegari A, Bonaguri C, Russo A, Luisita B, Trenti T, Lippi G (2012) A comparative study on the reliability of an automated system for the evaluation of cell-based indirect immunofluorescence. Autoimmun Rev 11:713–716

Egerer K, Roggenbuck D, Hiemann R, Weyer MG, Buttner T, Radau B, Krause R, Lehmann B, Feist E, Burmester GR (2010) Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests. Arthritis Res Ther 12:R40